Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomised, International Trial Comparing mFOLFIRINOX Triplet Chemotherapy to mFOLFOX for High-risk Stage III Colon Cancer in Adjuvant Setting

NCT02967289 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT02967289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02967289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomised, International Trial Comparing mFOLFIRINOX Triplet Chemotherapy to mFOLFOX for High-risk Stage III Colon Cancer in Adjuvant Setting
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Completed
Start date
March 27, 2017
Completion date
July 15, 2025
Enrollment
792 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer (high-risk stage iii: pt4n1 or pt1 to 4 n2)